These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 33525802)
1. The non-T-cell-inflamed tumor microenvironment: contributing factors and therapeutic solutions. Horton BL; Spranger S Emerg Top Life Sci; 2017 Dec; 1(5):447-456. PubMed ID: 33525802 [TBL] [Abstract][Full Text] [Related]
2. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment. Li X; Xiang Y; Li F; Yin C; Li B; Ke X Front Immunol; 2019; 10():2293. PubMed ID: 31616443 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Gene Signatures of Tumor Microenvironment Yields Insight Into Mechanisms of Resistance to Immunotherapy. Wang B; Liu M; Ran Z; Li X; Li J; Ou Y Front Bioeng Biotechnol; 2020; 8():348. PubMed ID: 32528935 [No Abstract] [Full Text] [Related]
14. Biomimetic and Self-Assembled Nanoclusters Targeting β-Catenin for Potent Anticancer Therapy and Enhanced Immunotherapy. Liu J; Yan J; Yan S; Wang Y; Zhang R; Hou P; He W; Ji M Nano Lett; 2019 Dec; 19(12):8708-8715. PubMed ID: 31744296 [TBL] [Abstract][Full Text] [Related]
15. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment. Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046 [TBL] [Abstract][Full Text] [Related]
16. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. Yang L; Li A; Lei Q; Zhang Y J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797 [TBL] [Abstract][Full Text] [Related]
17. Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy. Spranger S; Sivan A; Corrales L; Gajewski TF Adv Immunol; 2016; 130():75-93. PubMed ID: 26923000 [TBL] [Abstract][Full Text] [Related]
18. The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment. Gajewski TF Semin Oncol; 2015 Aug; 42(4):663-71. PubMed ID: 26320069 [TBL] [Abstract][Full Text] [Related]
19. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy. Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064 [TBL] [Abstract][Full Text] [Related]
20. Wnt Signaling in Cancer Metabolism and Immunity. El-Sahli S; Xie Y; Wang L; Liu S Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]